✦ LIBER ✦

Bicalutamide (“Casodex”) 150 mg as adjuvant to radiotherapy in localized or locally advanced prostate cancer

✍ Scribed by C. Tyrrell; H. Payne; W. See; D. McLeod; M. Wirth; P. Iversen; R. Beckman; K. Carroll

Book ID: 108434432
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 44 KB
Volume: 51
Category: Article
ISSN: 0360-3016
DOI: 10.1016/s0360-3016(01)01851-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bicalutamide (‘casodex’) 150 mg as adjuv

Bicalutamide (‘casodex’) 150 mg as adjuvant to radiotherapy in localised or locally advanced prostate cancer

✍ C. Tyrrell; H. Payne; M. Wirth; P. Iversen; W. See; D. McLeod; B.-E. Persson; K. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Bicalutamide (‘Casodex’) 150 mg as

Bicalutamide (‘Casodex’) 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme

✍ Chris J. Tyrrell; Heather Payne; William A. See; David G. McLeod; Manfred P. Wir 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 245 KB

Bicalutamide (Casodex) 150 mg as immedia

Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression

✍ M Wirth; C Tyrrell; M Wallace; K.P Delaere; M Sánchez-Chapado; J Ramon; J Hether 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 223 KB

BICALUTAMIDE 150 MG MAINTAINS BONE MINER

BICALUTAMIDE 150 MG MAINTAINS BONE MINERAL DENSITY DURING MONOTHERAPY FOR LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCER

✍ SIEBER, PAUL R.; KEILLER, DANNY L.; KAHNOSKI, RICHARD J.; GALLO, JOSE; MCFADDEN, 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 95 KB

Spotlight on Bicalutamide 150mg in the T

Spotlight on Bicalutamide 150mg in the Treatment of Locally Advanced Prostate Cancer

✍ Keri Wellington, Susan J. Keam 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 96 KB

Bicalutamide 150 mg as adjuvant to radio

Bicalutamide 150 mg as adjuvant to radiotherapy significantly increases progression-free survival in early prostate cancer

✍ H Payne; C Tyrrell; W.A See; D.G McLeod; M.P Wirth; P Iversen; L Garside 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 199 KB